Page last updated: 2024-08-26

bosentan anhydrous and MS (Multiple Sclerosis)

bosentan anhydrous has been researched along with MS (Multiple Sclerosis) in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beelen, R; Cambron, M; D'haeseleer, M; De Keyser, J; Demey, J; Fierens, Y; Vanbinst, AM; Verborgh, C	1
Drinovec, I; Jazbec, SS; Ledinek, AH; Rot, U	1

Other Studies

2 other study(ies) available for bosentan anhydrous and MS (Multiple Sclerosis)

Article	Year
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-02, Volume: 110, Issue:14 Topics: Astrocytes; Bosentan; Cerebrovascular Circulation; Endothelin-1; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Multiple Sclerosis; Spin Labels; Statistics, Nonparametric; Sulfonamides	2013
Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report. Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:7 Topics: Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Immunologic Factors; Interferon beta-1b; Interferon-beta; Multiple Sclerosis; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Young Adult	2009

Article

Year

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

Proceedings of the National Academy of Sciences of the United States of America, 2013, Apr-02, Volume: 110, Issue:14

Topics: Astrocytes; Bosentan; Cerebrovascular Circulation; Endothelin-1; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Multiple Sclerosis; Spin Labels; Statistics, Nonparametric; Sulfonamides

2013

Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report.

Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:7

Topics: Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Immunologic Factors; Interferon beta-1b; Interferon-beta; Multiple Sclerosis; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Young Adult

2009